Buprenorphine and Desipramine Treatment for Opiate and Cocaine Dependence
Data Collection
Narcotic-Related Disorders+2
+ Mental Disorders
+ Opioid-Related Disorders
Treatment Study
Summary
Study start date: August 1, 1988
Actual date on which the first participant was enrolled.This study focuses on helping individuals who are dealing with dependence on opiates and cocaine. It aims to assess the effectiveness of two medications, buprenorphine and desipramine, in managing these dependencies. The study is important as it could potentially provide a new treatment approach for those struggling with opiate and cocaine addiction, thereby improving their quality of life and overall health. During this study, participants receive either buprenorphine or desipramine as part of their treatment. The effectiveness of these medications is evaluated based on how well they help manage the participants' dependence. As with any study, there may be potential risks and benefits associated with participation, but these are carefully monitored to ensure the safety and well-being of all involved.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 65 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Please contact site for information.
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
VA Connecticut Healthcare System
New Haven, United StatesOpen VA Connecticut Healthcare System in Google Maps